Company news

Treace Medical Concepts, Inc. news in 2024

Treace Medical Concepts, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure

December 29, 2024

Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant

December 15, 2024

Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities

December 3, 2024

Treace Appoints Guy Guglielmino as Chief Commercial Officer

December 1, 2024

Treace Medical Concepts Reports Third Quarter 2024 Financial Results

November 4, 2024

Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure

November 3, 2024

Treace to Report Third Quarter 2024 Financial Results on November 5, 2024

October 21, 2024

Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology

October 13, 2024

Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024

September 10, 2024

Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 21, 2024

Treace Medical Concepts Reports Second Quarter 2024 Financial Results

August 5, 2024

Treace Medical Concepts Reports First Quarter 2024 Financial Results

May 6, 2024

Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour

April 23, 2024

Treace Announces First Annual National Bunion Day

April 15, 2024

Treace to Report First Quarter 2024 Financial Results

April 8, 2024

Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone

March 24, 2024

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

February 26, 2024

Treace to Report Fourth Quarter and Full-Year 2023 Financial Results

February 6, 2024

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

February 1, 2024

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue

January 7, 2024

Calls in 2024

Decks in 2024